Balwinder Singh is a Consultant and Assistant Professor of Psychiatry at Mayo Clinic. He completed medical school at Goa Medical College, India and gained a Master’s degree in Clinical & Transitional Science at Mayo Clinic. He completed a Psychiatry Residency (and Chief Residency) at the University of North Dakota School of Medicine in 2017. He is a recipient of the Alpha Omega Alpha Award and is a Fellow of the American Psychiatric Association. He is a member of the Mood Disorders Precision Medicine Consortium, The Global Bipolar Consortium, and the NNDC Biomarkers Task Force. He is interested in the neurobiology of mood disorders, novel treatments for mood disorders—especially ketamine—and investigating biomarkers to facilitate individualized treatment for treatment-resistant depression.